| 摘要 |
PHARMACEUTICAL COMPOSITIONS COMPRISING THE CANNABINOID ACTIVE PHARMACEUTICAL INGREDIENT, CRYSTALLINE TRANS-(T)-69-TETRAHYDROCANNABINOL, AND FORMULATIONS THEREOF ARE DISCLOSED. THE INVENTION ALSO RELATES TO METHODS FOR TREATING OR PREVENTING A CONDITION SUCH AS PAIN COMPRISING ADMINISTERING TO A PATIENT IN NEED THEREOF AN EFFECTIVE AMOUNT OF CRYSTALLINE TRANS-(T)-69-TETRAHYDROCANNABINOL. IN SPECIFIC EMBODIMENTS, THE CRYSTALLINE TRANS-(T)-69-TETRAHYDROCANNABINOL ADMINISTERED ACCORDING TO THE METHODS FOR TREATING OR PREVENTING A CONDITION SUCH AS PAIN CAN HAVE A PURITY OF AT LEAST ABOUT 98% BASED ON THE TOTAL WEIGHT OF CANNABINOIDS.
|
